Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Parkinson's Disease

  Free Subscription


12.02.2018

1 Exp Neurol
2 J Neural Transm (Vienna)
6 Mov Disord
1 Nat Rev Neurol
1 Neurosci Lett
2 Neuroscience
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Exp Neurol

  1. REN M, Guo Y, Wei X, Yan S, et al
    TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.
    Exp Neurol. 2018;302:205-213.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  2. SZOKO E, Tabi T, Riederer P, Vecsei L, et al
    Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.
    J Neural Transm (Vienna). 2018 Feb 7. pii: 10.1007/s00702-018-1853.
    PubMed     Text format     Abstract available

  3. PINNA A, Serra M, Morelli M, Simola N, et al
    Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia.
    J Neural Transm (Vienna). 2018 Feb 2. pii: 10.1007/s00702-018-1848.
    PubMed     Text format     Abstract available


    Mov Disord

  4. HOGL B, Stefani A
    Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations.
    Mov Disord. 2017;32:669-681.
    PubMed     Text format     Abstract available

  5. MCKENNA D, Peever J
    Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder.
    Mov Disord. 2017;32:636-644.
    PubMed     Text format     Abstract available

  6. LAGRAVINESE G, Pelosin E, Bonassi G, Carbone F, et al
    Gait initiation is influenced by emotion processing in Parkinson's disease patients with freezing.
    Mov Disord. 2018 Feb 2. doi: 10.1002/mds.27312.
    PubMed     Text format     Abstract available

  7. WEINTRAUB D, Hamilton JL, Eberling J, Litvan I, et al
    At a crossroads: Revisiting mild cognitive impairment in Parkinson's disease.
    Mov Disord. 2018 Feb 8. doi: 10.1002/mds.27310.
    PubMed     Text format    

  8. CREED RB, Goldberg MS
    New developments in genetic rat models of Parkinson's disease.
    Mov Disord. 2018 Feb 8. doi: 10.1002/mds.27296.
    PubMed     Text format     Abstract available

  9. BAHIRAEE A, Ebrahimi R
    A noble pathological role for alpha-synuclein in triggering neurodegeneration of Parkinson's disease.
    Mov Disord. 2018 Feb 8. doi: 10.1002/mds.27306.
    PubMed     Text format    


    Nat Rev Neurol

  10. RIDLER C
    Parkinson disease: LRRK2 variants linked to PD and Crohn's disease.
    Nat Rev Neurol. 2018 Feb 2. pii: nrneurol.2018.10. doi: 10.1038/nrneurol.2018.
    PubMed     Text format    


    Neurosci Lett

  11. SILVEIRA CRA, Roy EA, Almeida QJ
    Acute effects of aerobic exercise on cognitive function in individuals with Parkinson's disease.
    Neurosci Lett. 2018 Feb 3. pii: S0304-3940(18)30068.
    PubMed     Text format     Abstract available


    Neuroscience

  12. GILAT M, Ehgoetz Martens KA, Miranda-Dominguez O, Arpan I, et al
    Dysfunctional Limbic Circuitry Underlying Freezing of Gait in Parkinson's Disease.
    Neuroscience. 2018 Jan 31. pii: S0306-4522(18)30074.
    PubMed     Text format     Abstract available

  13. HUOTARINEN A, Penttinen AM, Back S, Voutilainen MH, et al
    Combination of CDNF and deep brain stimulation decreases neurological deficits in late-stage model Parkinson's disease.
    Neuroscience. 2018 Feb 3. pii: S0306-4522(18)30082.
    PubMed     Text format     Abstract available


    PLoS One

  14. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: